Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1996

View Archived Issues

ANOTHER THREAT TO PATENTABILITY OF GENE THERAPY THWARTED

CLARIFICATIONS

GENZYME'S FIRST CARTICEL DATA POSITIVE GENZYME, DIACRIN FORM JOINT

VIROPHARMA FILES IPO TO FUND WORK ON RNA VIRUSES

OTHER NEWS TO NOTE

BIOCRYST PHARMACEUTICALS COMPLETES $20M OFFERING

HIV SUPPRESSION TRACED TO SHORT DELETION IN GENE CRUCIAL TO VIRAL

PHASE III DATA POSITIVE FOR MAGAININ'S ANTI- INFECTIVE DRUG